EcoDrugPlus

Carbonic Anhydrase Iv C

Ensembl ID : ENSEEEG00000005548
Gene Symbol: CA4C
4 Cross references
201 Possible Orthologues:

Carbonic Anhydrase Vii

Ensembl ID : ENSEEEG00000018563
Gene Symbol: CA7
4 Cross references
222 Possible Orthologues:

Carbonic Anhydrase Va

Ensembl ID : ENSEEEG00000010517
Gene Symbol: CA5A
2 Cross references
231 Possible Orthologues:

Carbonic Anhydrase Xiv

Ensembl ID : ENSEEEG00000011858
Gene Symbol: CA14
1 Cross references
209 Possible Orthologues:

Casein Kinase 1 Epsilon

Ensembl ID : ENSEEEG00000011727
Gene Symbol: CSNK1E
4 Cross references
195 Possible Orthologues:

Casein Kinase 1, Epsilon

Ensembl ID : ENSEEEG00000011021
Gene Symbol: CSNK1E
4 Cross references
202 Possible Orthologues:

Caspase 9, Apoptosis-Related Cysteine Peptidase

Ensembl ID : ENSEEEG00000023785
Gene Symbol: CASP9
4 Cross references
204 Possible Orthologues:

Catechol-O-Methyltransferase A

Ensembl ID : ENSEEEG00000014928
Gene Symbol: COMTA
1 Cross references
168 Possible Orthologues:

Catechol-O-Methyltransferase B

Ensembl ID : ENSEEEG00000000388
Gene Symbol: COMTB
4 Cross references
211 Possible Orthologues:

Cathepsin C

Ensembl ID : ENSEEEG00000001326
Gene Symbol: CTSC
4 Cross references
239 Possible Orthologues:

Cathepsin K

Ensembl ID : ENSEEEG00000000158
Gene Symbol: CTSK
4 Cross references
240 Possible Orthologues:

Cathepsin S, Ortholog2, Tandem Duplicate 1

Ensembl ID : ENSEEEG00000000099
Gene Symbol: CTSS2.1
4 Cross references
237 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).